Dr. Reddy's Labs Files 6-K for Nov 2024
Ticker: RDY · Form: 6-K · Filed: Nov 4, 2024 · CIK: 1135951
Sentiment: neutral
Topics: filing, regulatory, foreign-private-issuer
Related Tickers: RDY
TL;DR
DRL filed a 6-K on Nov 4, 2024, confirming 20-F reporting.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 4, 2024, to report information as a foreign private issuer. The filing indicates the company is submitting its annual reports under cover of Form 20-F. The company's principal executive office is located in Hyderabad, Telangana, India.
Why It Matters
This filing is a routine update for foreign private issuers, confirming their reporting structure and providing contact information for regulatory purposes.
Risk Assessment
Risk Level: low — This is a standard procedural filing for a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-001115 (filing_id) — Accession Number
- 20241104 (date) — Filing Date
- Hyderabad, Telangana, India (location) — Principal Executive Office
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information to the SEC.
Which form does Dr. Reddy's Laboratories Ltd. use for its annual reports?
Dr. Reddy's Laboratories Ltd. indicates it files its annual reports under cover of Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on November 4, 2024.
Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?
The principal executive office of Dr. Reddy's Laboratories Ltd. is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the SEC file number for Dr. Reddy's Laboratories Ltd.?
The SEC file number for Dr. Reddy's Laboratories Ltd. is 001-15182.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-11-04 12:10:26
Filing Documents
- drr0688_6k.htm (6-K) — 13KB
- drr0688_ex99-1.htm (EX-99.1) — 8KB
- drr0688_ex99-1img01.jpg (GRAPHIC) — 4KB
- drr0688_ex99-1img02.jpg (GRAPHIC) — 6KB
- 0001575872-24-001115.txt ( ) — 37KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: November 04, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3